Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory
NCT ID: NCT03323450
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2017-10-20
2020-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT
NCT03096431
Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors
NCT02129712
Cognitive Rehabilitation in Brain Tumor Patients After Neurosurgery
NCT03373487
Working Memory Performance Among Childhood Brain Tumor Survivors
NCT00693914
Neural Bases of Cognitive Rehabilitation for Brain Injury
NCT01120756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High grade gliomas(WHO grade III or IV; n=15)
The two groups will follow identical study timelines. Participants will receive a 1 hour training session on CogMed® (PI or trained graduate student). Participants will complete 5 weeks of CogMed® training within their own home. It consists of 25 training sessions. Each session lasts 30-45 minutes.The study team will check in with participants once a week via phone or email. Brief neuropsychological evaluations will be conducted at 4 time points. Each assessment will take approximately 30-60 minutes. Each participant will receive a $25 gift card to the VCU medical center gift shop at two time points.
CogMed®
It consists of 25 training sessions which can all be completed online and at home. Each session lasts 30-45 minutes. They must have a computer at home compatible with the CogMed® program.
Brief neuropsychological evaluations will be conducted at 4 time points (these assessments are standard of care):
1. Baseline before the participant is introduced to the CogMed® training program
2. Within 2 weeks of completion of the CogMed® program
3. At 3 months of completion of the CogMed® program to establish maintenance of gains
4. At 6 months of completion of the CogMed® program to establish longer-term maintenance of gains
Low grade gliomas(WHO grade II; n=15)
The two groups will follow identical study timelines. Participants will receive a 1 hour training session on CogMed® (PI or trained graduate student). Participants will complete 5 weeks of CogMed® training within their own home. It consists of 25 training sessions. Each session lasts 30-45 minutes.The study team will check in with participants once a week via phone or email. Brief neuropsychological evaluations will be conducted at 4 time points. Each assessment will take approximately 30-60 minutes. Each participant will receive a $25 gift card to the VCU medical center gift shop at two time points.
CogMed®
It consists of 25 training sessions which can all be completed online and at home. Each session lasts 30-45 minutes. They must have a computer at home compatible with the CogMed® program.
Brief neuropsychological evaluations will be conducted at 4 time points (these assessments are standard of care):
1. Baseline before the participant is introduced to the CogMed® training program
2. Within 2 weeks of completion of the CogMed® program
3. At 3 months of completion of the CogMed® program to establish maintenance of gains
4. At 6 months of completion of the CogMed® program to establish longer-term maintenance of gains
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CogMed®
It consists of 25 training sessions which can all be completed online and at home. Each session lasts 30-45 minutes. They must have a computer at home compatible with the CogMed® program.
Brief neuropsychological evaluations will be conducted at 4 time points (these assessments are standard of care):
1. Baseline before the participant is introduced to the CogMed® training program
2. Within 2 weeks of completion of the CogMed® program
3. At 3 months of completion of the CogMed® program to establish maintenance of gains
4. At 6 months of completion of the CogMed® program to establish longer-term maintenance of gains
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A minimum of 2 months post-surgical resection or biopsy(if applicable)
* and/or a minimum 1 month post radiation treatment (if applicable)
* Karnofsky performance status more than 60
* Estimated intelligence at least 80 (standard score)
* Demonstrated attention difficulties (T-score of at least 65 on attention questionnaire or 1 or more standard deviations below mean on direct attention measures)
* No history of cognitive disorder
* No history of mood disorder
* Predicted life expectancy of at least 12 months
* Computer capability at home or provided a departmental iPad Mini to borrow for study purposes
* Primarily English speaking
* Aged 18+ (for which there is available age-adjusted neuropsychological testing standardization / normative data)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashlee Loughan, PhD
Role: PRINCIPAL_INVESTIGATOR
Massey Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University/Massey Cancer Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Braun SE, Aslanzadeh FJ, Lanoye A, Fountain-Zaragoza S, Malkin MG, Loughan AR. Working memory training for adult glioma patients: a proof-of-concept study. J Neurooncol. 2021 Oct;155(1):25-34. doi: 10.1007/s11060-021-03839-y. Epub 2021 Sep 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCC-17-13581
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.